Poorly writen news!How this company can take good news and make it look bad is beyond me. Completely incompetent. The news was that they received approval to test at higher amounts. Which is good! But they made it seems like all negotiations are now hanging on these trials which is not the case. Negotiations are ongoing and this does not hurt but will help partners in the future that want to split up the market to potentially make more revenue. These guys are a screw up. A deal will come!